United States · 
What does Third Rock Ventures invest in?
Third Rock Ventures invests most often at Series A and Series B (81% of the rounds on record), in sectors such as Biotech, Pharmaceuticals and Bio.
Third Rock Ventures highlights
- 01
84 rounds on record
- 02
Mostly Series A and Series B: 81% of its rounds
- 03
Sole investor in 15 rounds, median $47M
- 04
5 exits from the portfolio
What they do
Third Rock Ventures is a leading healthcare venture firm focused on advancing disruptive areas of science and medicineFrom their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $5.0M – $100M as they say
- Stages
- Pre-seed
- Sectors
- BiotechPharmaceuticalsBio
- Based in
- Boston, United States
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first84 appearances
- 2019
3 rounds
- Jul
- May
- Apr
- 2018
6 rounds
- Aug
- Jun
- May
- Apr
- Apr
- Mar
- 2017
5 rounds
- Dec
- Oct
- May
- Mar
- Feb
- 2016
4 rounds
- Dec
- Nov
- Sept
- Jul
- 2015
6 rounds
- Oct
- Oct
- Aug
- Aug
- Feb
- Jan
- 2014
10 rounds
- Dec
- Jul
- May
- Apr
- Apr
- Mar
- Mar
- Feb
- Jan
- Jan
- 2013
7 rounds
- Nov
- Oct
- Jul
- Mar
- Mar
- Feb
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration15 named
ACAbbie CelnikerManager of the GPLLC.iFiling they signed
ABAlexis BorisyManager of the GPLLC.iFiling they signed
ACAlison ConnorsChief Financial OfficeriForm ADV
AVAndrea van ElsasManager of the GPLLC.iFiling they signed
CPCary PfefferManager of the GPLLC.iFiling they signed
CMCraig MuirManager of the GPLLC.iFiling they signed
DKDavid KaufmanManager of the GPLLC.iFiling they signed
JKJeffrey K TongManager of the GPLLC.iFiling they signed
JRJigar RaythathaManager of the GPLLC.iFiling they signed
KMKevin Michael GillisChief Operating OfficeriForm ADV
KSKevin StarrManager of the General Partner's general partner.iFiling they signed
MLMark LevinManager of the General Partner's general partner.iFiling they signed
NENeil ExterManager of the GPLLC.iFiling they signed
RMReid M HuberManager of the GPLLC.iFiling they signed
RIRobert Ira TepperManager of the General Partner's general partner.iFiling they signed
We also hold 41 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$1.9Bgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Third ROCK Ventures, LLC
- SEC number
- CRD 161185
What they claim to have backed
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed5 in all
Foundation MedicineBought by RocheUndisclosedJan 2015
Foundation MedicineListed$108MJul 2013
bluebird bioListed$101MJun 2013
Agios PharmaceuticalsListed$86MJun 2013
Alnara PharmaceuticalsBought by Eli LillyUndisclosedJul 2010
An exit counts when it came after the firm's first round in the company. From historical deal records.